(Q37990890)

26 August 2017

title

Fracture risk and bone mineral density reduction associated with proton pump inhibitors (English)

1 reference

26 August 2017

1 reference

Yuen Ting Lau

1

1 reference

26 August 2017

Nasiya N Ahmed

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

1 January 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

32

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

67-79

1 reference

Gastric H,K-ATPase as a drug target

26 August 2017

cites work

1 reference

Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm

21 January 2018

1 reference

Proton pump inhibitor omeprazole use is associated with low bone mineral density in maintenance haemodialysis patients

21 January 2018

1 reference

Long-term proton pump inhibitor therapy and risk of hip fracture

21 January 2018

1 reference

Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients

21 January 2018

1 reference

Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study

21 January 2018

1 reference

Use of proton pump inhibitors and risk of osteoporosis-related fractures

21 January 2018

1 reference

Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative

21 January 2018

1 reference

Acid-suppressive medications and risk of bone loss and fracture in older adults

21 January 2018

1 reference

Increase in vertebral fracture risk in postmenopausal women using omeprazole

21 January 2018

1 reference

Multiple vertebral fractures are associated with refractory reflux esophagitis in postmenopausal women

21 January 2018

1 reference

Proton pump inhibitor use and the antifracture efficacy of alendronate

21 January 2018

1 reference

Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study

21 January 2018

1 reference

Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates

21 January 2018

1 reference

Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies.

21 January 2018

1 reference

Meta-analysis: risk of fractures with acid-suppressing medication

21 January 2018

1 reference

Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

Use of proton-pump inhibitors and their associated risks among frail elderly nursing home residents

21 January 2018

1 reference

Gastrointestinal absorption of calcium from milk and calcium salts.

21 January 2018

1 reference

Calcium absorption and achlorhydria.

21 January 2018

1 reference

Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial

21 January 2018

1 reference

Bone mineral density in patients taking H2-receptor antagonist.

21 January 2018

1 reference

Do proton pump inhibitors decrease calcium absorption?

21 January 2018

1 reference

Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans.

21 January 2018

1 reference

Effect of omeprazole, an inhibitor of H+,K(+)-ATPase, on bone resorption in humans

21 January 2018

1 reference

Selective inhibition of osteoclast vacuolar H(+)-ATPase

21 January 2018

1 reference

Function, structure and regulation of the vacuolar (H+)-ATPases

21 January 2018

1 reference

Proton pump inhibitor therapy and osteoporosis

21 January 2018

1 reference

Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases

21 January 2018

1 reference

Effect of Birth Cohort on Risk of Hip Fracture: Age-Specific Incidence Rates in the Framingham Study

21 January 2018

1 reference

Proton-Pump Inhibitor Use Is Not Associated With Osteoporosis or Accelerated Bone Mineral Density Loss

21 January 2018

1 reference

Proton Pump Inhibitor Use and Risk of Hip Fractures in Patients without Major Risk Factors

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PHAR.1007

1 reference

release_66a54q2l3netjeccu5ivh5pu7e

26 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/66a54q2l3netjeccu5ivh5pu7e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference